Healthpeak Properties, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Healthpeak Properties reports increased net income driven by real estate gains, but FFO declines amidst strategic investments and operational costs.
NYSE
Healthpeak Properties, Inc. reported a net loss of $117.3 million for Q3 2025, primarily due to significant impairment charges in its lab joint ventures, despite revenue growth.
NYSE
Healthpeak Properties, Inc. reported a significant decline in GAAP net income for Q2 2025 and the first half of 2025 due to fewer asset sales and non-recurring gains in the prior year, while core operational metrics like FFO as Adjusted and AFFO showed growth driven by merger synergies and CCRC performance.
NYSE
Healthpeak Properties reports a significant increase in net income attributable to Healthpeak Properties, Inc. for Q1 2025, driven by merger synergies and portfolio growth.
NYSE
Healthpeak Properties' Q3 2024 results reflect the impact of its merger with Physicians Realty Trust, strategic asset sales, and ongoing development activities.
NYSE
Healthpeak Properties reports a significant increase in net income and revenue for the second quarter of 2024, driven by the recent merger with Physicians Realty Trust and strategic asset dispositions.
NYSE
Healthpeak Properties' first quarter 2024 results reflect the impact of its recent merger with Physicians Realty Trust, showing increased revenues but also higher expenses.